Safety and Efficacy of Microwave Ablation to Treat Pulmonary Nodules with Hydromorphone Versus Morphine
1.1. Rationale and Objective: To compare the safety and efficacy of computed tomography-guided percutaneous microwave abla tion (MWA) in treating pulmonary nodules under conscious anal go-sedation with hydromorphone versus morphine. 1.2. Materials and Methods: This was a retrospective before– after study. Between October 2020 and June 2022, 358 patients with 390 pulmonary nodules underwent 358 MWAs. Of these 358 patients who had consented to receive MWA treatment, 108 patients received morphine (group A) and 250 patients received hydromorphone (Group B). The individual characteristics of each patient and lesion, as well as technical information, clinical in formation, opioid-related complication, and numeric rating scale (NRS, 0=none, 10=worst) were collected and analyzed.